Revenue and Sales Performance - Revenue for Q3 2025 was $8.0 million, representing an increase of $3.7 million or 85% compared to Q3 2024, driven by strong demand for defense products [176]. - Revenue for the fiscal quarter ended September 28, 2025 was $8.0 million, an increase of $3.7 million or 85% compared to $4.3 million for the same quarter in the prior year, primarily driven by sales to South Korean defense contractors [201]. - Revenue for the fiscal year-to-date ended September 28, 2025 was $20.6 million, a 54% increase from $13.4 million in the prior year, driven by sales to South Korean defense contractors [211]. - Over $20 million of products were shipped to customers in the defense and industrial markets for the fiscal year-to-date ended September 28, 2025 [175]. Research and Development - Research and development expenses are expected to increase as Enovix ramps up engineering operations and hires additional personnel to support product development [194][196]. - Research and development expenses for the fiscal quarter ended September 28, 2025 were $28.2 million, up $4.0 million or 16% from $24.2 million in the prior year, attributed to increased salaries and depreciation [203]. - Research and development expenses for the fiscal year-to-date ended September 28, 2025 were $82.3 million, down $19.8 million or 19% from $102.1 million in the prior year, mainly due to reduced depreciation and lower headcount [213]. Financial Performance - Net loss for the fiscal quarter ended September 28, 2025 was $53.8 million, an increase of $31.1 million or 138% from a net loss of $22.6 million in the prior year [210]. - Total operating expenses for the fiscal year-to-date ended September 28, 2025 were $136.9 million, a decrease of $68.2 million or 33% from $205.1 million in the prior year, primarily due to the absence of restructuring costs [210]. - Interest expense surged to $11.8 million for the fiscal quarter ended September 28, 2025, a significant increase of $10.0 million or 585% compared to $1.7 million in the prior year, largely due to a one-time charge related to convertible senior notes [207]. - Interest income for the fiscal year-to-date ended September 28, 2025 was $7.4 million, a decrease of $2.3 million or 24% compared to $9.7 million for the same period in 2024 [219]. - Interest expense increased by $10.1 million or 200% to $15.2 million for the fiscal year-to-date ended September 28, 2025, primarily due to a one-time charge of $9.2 million related to Warrants issued [220]. Capital and Financing Activities - Enovix issued $360.0 million in 2030 Convertible Senior Notes, with net proceeds of $348.6 million intended for general corporate purposes and potential acquisitions [183]. - The company issued $360.0 million aggregate principal amount of 2030 Convertible Senior Notes with an interest rate of 4.75% during the fiscal quarter ended September 28, 2025 [228]. - The company holds $172.5 million of 2028 Convertible Senior Notes at an annual interest rate of 3.00% and $360.0 million of 2030 Convertible Senior Notes at an annual interest rate of 4.75%, accounting for approximately 98% of total debt [252]. - The company repurchased 5,437,556 shares of common stock for $58.4 million for the fiscal year-to-date ended September 28, 2025, with $1.6 million remaining under the Repurchase Plan [229]. Cash Flow and Investments - Net cash used in operating activities was $68.3 million for the fiscal year-to-date ended September 28, 2025, compared to $92.7 million for the same period in 2024, reflecting a decrease of $24.4 million [233][236]. - Net cash used in investing activities was $339.2 million for the fiscal year-to-date ended September 28, 2025, primarily due to $370.1 million in short-term investment purchases [237]. - Net cash provided by financing activities was $470.7 million for the fiscal year-to-date ended September 28, 2025, significantly higher than $44.2 million for the same period in 2024 [240][242]. - As of September 28, 2025, the company had cash and short-term investments totaling $560.8 million and an accumulated deficit of $942.8 million [224]. - As of September 28, 2025, the company had cash, cash equivalents, restricted cash, and investments totaling $650.3 million [251]. Strategic Focus and Market Position - The company is focused on five strategic market sectors: Smartphone, IoT, Computing, Defense, and Electric Vehicles [178]. - Enovix's commercialization strategy aims to establish the AI-1™ battery products as the baseline design for hardware platforms, facilitating broader adoption across device makers [180]. - The AI-1™ smartphone battery achieved the highest energy density reported for a smartphone battery, validated by an independent testing firm [176][185]. - Enovix delivered over 1,000 AI-1™ battery packs to its lead customer and samples to nine other smart eyewear OEMs and ODMs, with product launches expected in 2026 [174][181]. Other Financial Metrics - Selling, general and administrative expenses decreased by $0.6 million or 3% to $20.2 million for the fiscal quarter ended September 28, 2025, primarily due to a reduction in stock-based compensation expenses [204]. - Other income, net for the fiscal year-to-date ended September 28, 2025 was $1.5 million, an increase of $3.0 million compared to a loss of $1.5 million for the same period in 2024, mainly due to a one-time import duty forgiveness of $2.4 million [221][222]. - Income tax benefit decreased by $1.1 million or 43% to $1.4 million for the fiscal year-to-date ended September 28, 2025, primarily due to lower tax benefits from losses in certain foreign jurisdictions [223]. Risk Management - The company does not believe it is exposed to material interest rate risk due to its borrowing activities [252]. - A hypothetical 10% adverse change in foreign currency exchange rates would not have a material effect on the company's financial condition or results of operations [254]. - The company has not entered into derivative or hedging transactions for foreign currency risks but may do so in the future as international operations grow [255].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended - September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36192 Civista Bancshares, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employ ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38101 WideOpenWest, Inc. (Exact name of registrant as specified in its charter) Delaware (State or Other Jurisdiction o ...

EX-99.1 2 ltbr_ex991.htm PRESS RELEASE EXHIBIT 99.1 Lightbridge Provides Business Update and Announces Third Quarter 2025 Financial Results RESTON, Va, November 5, 2025 (GLOBE NEWSWIRE) – Lightbridge Corporation ("Lightbridge" or the "Company") (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the third quarter and nine months ended September 30, 2025, and provided an update on the Company's continued progress. Seth Grae, President & Chief Executive Officer of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-8590 MURPHY OIL CORPORATION (Exact name of registrant as specified in its charter) Delaware 71-0361522 (I.R.S. Employer Identi ...

Exhibit 99.1 Blue Owl Capital Corporation Announces September 30, 2025 Financial Results NEW YORK — November 5, 2025 — Blue Owl Capital Corporation (NYSE: OBDC) ("OBDC" or the "Company") today announced financial results for its third quarter ended September 30, 2025. (2) Dividend yield based on OBDC's annualized Q3 2025 regular dividend of $0.37 per share payable to shareholders of record as of September 30, 2025, and Q3 2025 NAV per share of $14.89. • Third quarter GAAP net investment income ("NII") per s ...

Financial Performance - Revenue for Q3 2025 was $132.8 million, a decrease of 15.2% compared to $156.7 million in Q3 2024[11] - Gross profit for Q3 2025 was $28.0 million, down 36.3% from $43.9 million in Q3 2024[11] - Net income for the nine months ended September 30, 2025, was $7.9 million, an increase of 16.9% compared to $6.8 million for the same period in 2024[14] - Operating profit for the nine months ended September 30, 2025, was $11.1 million, down 43.5% from $19.6 million in the same period of 2024[11] - The net income for the three months ended September 30, 2025, was $1,653,000, compared to a net income of $5,986,000 for the same period in 2024[22] - Basic earnings per share for Q3 2025 were $0.12, compared to $0.14 in Q3 2024[11] - Comprehensive income for the nine months ended September 30, 2025, was $8.3 million, compared to $9.9 million for the same period in 2024[14] - Total revenues for the three months ended September 30, 2025, were $132.8 million, a decrease of 15.2% compared to $156.7 million for the same period in 2024[55] - Consumer product revenue for the nine months ended September 30, 2025, was $340.8 million, down 13.6% from $394.4 million in 2024[55] - Commercial product revenue increased to $42.4 million for the nine months ended September 30, 2025, compared to $39.9 million in 2024, reflecting a growth of 6.3%[55] - Licensing revenue for the nine months ended September 30, 2025, was $6.8 million, up 41.7% from $4.8 million in 2024[55] Assets and Liabilities - Total assets as of September 30, 2025, were $392.4 million, a decrease of 5.4% from $415.1 million at the end of 2024[9] - Total liabilities decreased to $228.3 million as of September 30, 2025, down 8.4% from $249.2 million at the end of 2024[9] - Cash and cash equivalents at the end of Q3 2025 were $17.2 million, a decrease of 24.5% from $22.6 million at the end of Q3 2024[9] - Total stockholders' equity as of September 30, 2025, was $164,048,000, with retained earnings of $126,953,000[20] - The company has $54.4 million in outstanding payment obligations to a third-party financial institution as of September 30, 2025[36] Shareholder Activities - The company paid cash dividends of $0.12 per share during the third quarter of 2025, totaling $1,619,000[20] - The company repurchased 396,065 shares for an aggregate purchase price of $7.2 million during the nine months ended September 30, 2025[42] - The company repurchased 39,333 shares for $0.6 million during the three months ended September 30, 2025, compared to 221,529 shares for $5.3 million in 2024[44] - As of September 30, 2025, the company had $4.2 million remaining authorized for share repurchase[42] Credit and Financing - The company has a $125.0 million senior secured floating-rate revolving credit facility expiring on December 13, 2029, which is expected to provide sufficient liquidity for operating needs[29] - The fair value of the HBB Facility was $125.0 million, determined using current rates for similar obligations[41] Environmental and Regulatory Matters - As of September 30, 2025, the Company accrued undiscounted obligations of $3.0 million for environmental investigation and remediation activities, down from $3.9 million as of December 31, 2024[58] - The Company estimates additional expenses related to environmental investigation and remediation could range from $0 to $1.0 million[58] Acquisitions - The Company completed the acquisition of HealthBeacon Limited for €6.9 million (approximately $7.5 million) on February 2, 2024[63] - HealthBeacon generated revenue of $1.887 million and an operating profit of $313,000 for the three months ended September 30, 2025[65] - The total assets acquired from HealthBeacon amounted to $10.191 million, with total liabilities of $2.632 million[67] Taxation - The effective tax rate for the three months ended September 30, 2025, was 18.4%, a decrease from 27.4% in the same period of 2024, primarily due to increased foreign derived tax benefits[60] Other Financial Information - The company reported a net cash used in operating activities of $14.6 million for the nine months ended September 30, 2025[17] - The company reported a share-based compensation expense of $569,000 for the three months ended September 30, 2025[20] - The company incurred transaction costs of approximately $0.2 million and $1.3 million during the three and nine months ended September 30, 2024, respectively[66] - The company completed the termination of its U.S. Pension Plan in 2024, with a pre-tax settlement charge of $7.6 million recognized in the third quarter of 2024[33] - The company transferred $13.4 million of surplus assets to a qualified replacement plan for employee retirement benefits in the first quarter of 2025[34] - The company expects revenue to increase during the second half of the year, peaking in the fourth quarter due to the fall holiday-selling season[28]

National Healthcare Properties Reports Third Quarter 2025 Results NEW YORK, November 5, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the "Company"), a self-managed diversified healthcare real estate investment trust focusing on seniors housing and outpatient medical facilities, today announced results for the three and nine months ended September 30, 2025. Michael Anderson, Chief Executive Officer and President, commented, "We are very pleased with the continued str ...

Operating Update NEW YORK, November 5, 2025 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the "Company"), a self-managed diversified healthcare real estate investment trust focusing on seniors housing and outpatient medical facilities, today announced results for the three and nine months ended September 30, 2025. Michael Anderson, Chief Executive Officer and President, commented, "We are very pleased with the continued strong momentum of our business across-the-board in ...

EXHIBIT 99.1 NEWS RELEASE MURPHY OIL CORPORATION ANNOUNCES THIRD QUARTER RESULTS Delivered Sequential Increase in Production to 200 MBOEPD and 94 MBOPD Reduced Debt by $50 Million and Paid Dividends of $46 Million Progressed Lac Da Vang (Golden Camel) Platform Jacket Installation and Pipeline Laying Campaign in Vietnam Ahead of Schedule HOUSTON, Texas, November 5, 2025 – Murphy Oil Corporation (NYSE: MUR) today announced its financial and operating results for the third quarter ended September 30, 2025. As ...